Literature DB >> 10838604

Anandamide and the question of its functional role for activation of capsaicin receptors.

J Szolcsányi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10838604     DOI： 10.1016/s0165-6147(00)01484-x

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN： 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  8 in total

1.  Interaction between vanilloid receptors and purinergic metabotropic receptors: pain perception and beyond.

Authors:  L S Premkumar
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

2.  Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens.

Authors:  R A Ross; T M Gibson; H C Brockie; M Leslie; G Pashmi; S J Craib; V Di Marzo; R G Pertwee
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

3.  Anandamide activates peripheral nociceptors in normal and arthritic rat knee joints.

Authors:  S D Gauldie; D S McQueen; R Pertwee; I P Chessell
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

4.  Stimulation of pulmonary vagal C-fibres by anandamide in anaesthetized rats: role of vanilloid type 1 receptors.

Authors:  You Shuei Lin; Lu-Yuan Lee
Journal:  J Physiol       Date:  2002-03-15       Impact factor: 5.182

Review 5.  Cannabinoids and neuroprotection.

Authors:  R I Grundy; M Rabuffetti; M Beltramo
Journal:  Mol Neurobiol       Date:  2001 Aug-Dec       Impact factor: 5.590

6.  Characterization of the anandamide induced depolarization of guinea-pig isolated vagus nerve.

Authors:  Manabu Kagaya; Jasmine Lamb; Jon Robbins; Clive P Page; Domenico Spina
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

Review 7.  Brain activity of anandamide: a rewarding bliss?

Authors:  Maria Scherma; Paolo Masia; Valentina Satta; Walter Fratta; Paola Fadda; Gianluigi Tanda
Journal:  Acta Pharmacol Sin       Date:  2018-07-26       Impact factor: 6.150

Review 8.  Modulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addiction.

Authors:  Stéphanie Olière; Antoine Joliette-Riopel; Stéphane Potvin; Didier Jutras-Aswad
Journal:  Front Psychiatry       Date:  2013-09-23       Impact factor: 4.157
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.